Publications by authors named "Peter D Beitsch"

Claim this Profile
U
Utilization of Cancer Screening, Prevention, and Treatment in Women With Variants of Uncertain Significance in Breast Cancer Susceptibility Genes.
Sarah M Nielsen, Emily M Russell, Rachel E Ellsworth, Kevin S Hughes, Brandie Heald, Peter D Beitsch

J Natl Compr Canc Netw· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer.
Alejandro Ríos-Hoyo, Erin Cobain, Laura A Huppert, Peter D Beitsch, Thomas A Buchholz

J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancer.
James V Pellicane, Peter D Beitsch, David T Rock, Raye J Budway, Carrie L Dul

Surg Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.

JAMA Surg· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.
Pat W Whitworth, Peter D Beitsch, Mary K Murray, Paul D Richards, Angela Mislowsky

JCO Precis Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.
Pat W Whitworth, Peter D Beitsch, Rakesh Patel, Barry Rosen, Gia Compagnoni

JAMA Netw Open· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
Pat Whitworth, Peter D Beitsch, James V Pellicane, Paul L Baron, Laura A Lee

Ann Surg Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature.
Pat W Whitworth, Peter D Beitsch, James V Pellicane, Paul L Baron, Laura A Lee

JCO Precis Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction.
Eric D Whitman, Vadim P Koshenkov, Brian R Gastman, Deri Lewis, Eddy C Hsueh, Peter D Beitsch

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results From a Large Multicenter Trial.
John F Thompson, Lauren E Haydu, Roger F Uren, Robert H Andtbacka, Jonathan S Zager, Peter D Beitsch

Ann Surg· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
Michael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, Alastair M Thompson, Richard J Bold, Peter D Beitsch

Ann Surg Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
Michael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, Alastair M Thompson, Richard J Bold, Peter D Beitsch

Ann Surg Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.
Mi Jeong Kwon, Sae Byul Lee, Jinil Han, Jeong Eon Lee, Jong Won Lee, Peter D Beitsch

PLoS One· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D Beitsch, Pat W Whitworth, Kevin Hughes, Rakesh Patel, Barry Rosen

J Clin Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Armando E Giuliano, Karla V Ballman, Linda McCall, Peter D Beitsch, Meghan B Brennan

JAMA· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
Mark B Faries, John F Thompson, Alistair J Cochran, Robert H Andtbacka, Nicola Mozzillo, Peter D Beitsch

N Engl J Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Breast Specialists 2.0: Rethinking the Future of Breast Fellowship Training.
Peter D Beitsch, Pat Whitworth

Ann Surg Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.
Kelly M McMasters, Michael E Egger, Michael J Edwards, Merrick I Ross, Douglas S Reintgen, Peter D Beitsch

J Clin Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can breast surgeons provide breast cancer genetic testing? An American Society of Breast Surgeons survey.
Peter D Beitsch, Pat W Whitworth

Ann Surg Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Breast Surgeons presidential address: breast cancer surgery is dead…or is it?
Peter D Beitsch

Ann Surg Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).
Pat Whitworth, Lisette Stork-Sloots, Femke A de Snoo, Paul Richards, Michael Rotkis, Peter D Beitsch

Ann Surg Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postsurgical treatment of early-stage breast cancer with electronic brachytherapy: outcomes and health-related quality of life at 1 year.
Rakesh R Patel, Peter D Beitsch, Timothy D Nichols, John D Lorenzetti, James C Wurzer

Am J Clin Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite Registry Trial Data.
J Ben Wilkinson, Peter D Beitsch, Chirag Shah, Doug Arthur, Bruce G Haffty

Int J Radiat Oncol Biol Phys· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor bed control with balloon-based accelerated partial breast irradiation: incidence of true recurrences versus elsewhere failures in the American Society of Breast Surgery MammoSite(®) Registry Trial.
Peter D Beitsch, J Ben Wilkinson, Frank A Vicini, Bruce Haffty, Richard Fine

Ann Surg Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial.
Kelly K Hunt, Karla V Ballman, Linda M McCall, Judy C Boughey, Elizabeth A Mittendorf, Peter D Beitsch

Ann Surg· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis